Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
15.32 1.60(11.66%) Jul 25, 3:59PM EDT
Prev Close:13.72
Open:14.03
Bid:14.60 x 200
Ask:N/A
1y Target Est:29.50
Beta:0.88
Next Earnings Date:N/A
Day's Range:13.95 - 16.55
52wk Range:4.80 - 19.11
Volume:1,804,957
Avg Vol (3m):280,133
Market Cap:335.63M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTUp 11.66%335.63M
MNTA555.66M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.94
Quarterly EPS Est (Jun-14) :-0.21
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback